특별한 이슈정리, 토큐 하나면 족합니다.더보기
정부, 의대정원 확대 추진
정부가 의대정원 확대에 나서면서 의료계에 반발이 일고 있다.
의대 증원 규모 논란…정부 수요조사
정부가 의대 증원을 확실시 하며 구체적인 증원 규모를 정하기 위해 수요 조사에 나섰다.
큐레이터 조운 기자
연이은 한의사 현대의료기기 사용 허용 판결
최근 연이어 한의사들의 현대의료기기 사용을 허가하는 사법부 판결이 나오고 있다.
응급의학과 전공의 지원 추락
정부가 대구시에서 발생한 '응급실 뺑뺑이' 사건의 책임을 의료기관과 응급의학과 의사에게 물으면서 응급의학과 전공의 지원율이 급감하고 있다.
큐레이터 조운 기자
의협 임시총회 개최, 이필수 회장 탄핵 여론 '증폭'
대한의사협회 이필수 회장과 이정근, 이상운 부회장에 대한 불신임 임총이 개최된다. 표결 여부에 따라 집행부 탄핵과 비상대책위원회 구성이 이뤄질 가능성이 점쳐진다.
검체검사 수천건 부당청구로 삭감, 특단의 대책이 필요하다
[메디게이트뉴스] 최근에 친한 원장 한분이 수천건의 부당청구를 했다는 심사결정통보서를 받았다. 해당 원장은 평소에 한 건의 부당청구도 용납하지 않을 만큼 꼼꼼하게 청구하고 정직하게 진료하는 만큼 이런 통보서에 깜짝 놀랄 수 밖에 없었다고 한다. 그 이유를 알아보니 검체검사 질가산교육을 이수하지 않아서 교육이수 후에 청구할 수 있는 2%의 가산금액이 부당청구된 것이었다. 그나마 다행인 것은 삭감된 금액이 수십만원에 불과하다는 점이다. 의원급 의료기관이 검체검사 질가산을 받기 위해서는 상근의사가 대한의사협회에서 실시하는 검체검사 질가산 관련 교육을 받아야 한다. 하지만 검체검사 질가산 교육은 이수일로부터 1년간만 검체검사 질 가산 수가 항목을 산정받을 수 있는 규정이 있다. 개원의 입장에선 매년 교육날짜를 일일히 챙겨야 하고 심지어 해마다 날짜를 당겨서 교육받아야 하는 애로사항이 있다. 이 때문에 교육시기를 놓치는 의료기관이 발생하고 있다. 뒤늦게 교육날짜에 맞춰 교육을 신청하려고 해도 교육 인원이 초과되면 해당 날짜에 교육을 받지 못하는 경우도 생기곤 한다. 의료인 면허신고를 위한 보수교육은 1년에 최소 8시간을 이수하고 3년이 되면 12월 말까지 신고하도록 규정돼 있다. 의료법 이외의 다른 법에서 규정하는 법정의무교육도 해당년도 내에 받도록 돼 있다. 심지어 청구를 위해 이수해야 다른 인증교육들도 대체로 종료날짜가` 12월 31일이다. 최근 생긴 일차의료만성질환관리 교육도 이수한 다음 해 12월 31일까지 인정된다. 질 가산 교육이수 등록과정 교육등록 과정 www.hurb.or.kr - 현황신고 변경 - 인력현황 - 의(약/조산)사 신고 - 신규신고- 면허종별 의사로 변경 후 조회 - 조회 후 의사이름 클릭 - 신고대상목록 -자격등록- 스크롤바 내린 후 검체검사 질가산 교육 이수일자 입력 - 적용종료일자는 교육이수년도 1년 후로 입력 검체검사 질가산 교육만은 무조건 교육받은 날짜부터 일년 후에 종료되기 때문에 정확히 날짜를 계산해서 교육을 받아야 한다. 이런 식으로 검체검사 질가산교육만 이렇게 정확히 365일로 규정을 정한 것은 이해할 수 없다. 질 가산 교육은 매년 받고 있는 것이므로 한달 늦게 받는다고 하여 검체검사의 질이 현저하게 저하된다고 할 수 없다. 건강보험재정에 엄청나게 이득이 되는 것도 아니다. 만약 365일 규정이 검체검사 질가산 교육에서 필수불가결한 요소라면 교육을 받아야 하는 의료기관이 시기를 놓치지 않도록 안내하는 시스템이라도 갖춰야 마땅하다 .검체검사 질가산 교육의 목적이 검사의 질을 일정하게 유지하는 것이므로 적정한 시점에 교육을 받을 수 있도록 안내하는 것도 인증기관의 역할이다. 더구나 현재 보건복지부는 2024년 의원급 환산지수 결정안은 전체 환산지수를 1.6% 인상하되, 검체와 기능, 영상 관련 환산지수는 동결하고 이에 확보된 재정은 필수의료 분야에 투입하는 환산지수를 차등 적용한다고 발표했다. 가뜩이나 검체검사는 상대가치점수가 상대적으로 낮게 느껴질 수밖에 없는데 질 가산을 적용하면 교육점수의 영향력이 더욱 커진다. 이에 당장 교육인증 적용종료일을 12월31일로 통일하거나 질가산 시기 알람 시스템을 갖출 적절한 타이밍이다. 특단의 대책이 필요하다. 2024 [개정] 의원급(의원, 치과의원) 교육이수기관의 질가산 등급 (1) 1등급(90점 이상): 소정점수의 8% 가산 (2) 2등급(80점 이상 ~ 89점 이하): 소정점수의 6% 가산 (3) 3등급(70점 이상 ~ 79점 이하): 소정점수의 4% 가산 (4) 4등급(60점 이상 ~ 69점 이하): 소정점수의 3% 가산 (5) 5등급(40점 이상 ~ 59점 이하): 소정점수의 2% 가산 (6) 6등급(20점 이상 ~ 39점 이하): 소정점수의 1% 가산 (7) 7등급(20점 미만): 가산 없음 ※칼럼은 칼럼니스트의 개인적인 의견이며 본지의 편집방향과 일치하지 않을 수 있습니다.
의대증원이 불러올 '낙수' 효과 아닌 '누수' 효과
[메디게이트뉴스] 존경과 신뢰는 사라지고, 불신과 불안이 가득한 사회다. 의료 현장에서의 문제도 여기서 비롯된다. 환자들이 의사를 믿지 못하고, 의사들도 국민과 국가로부터 상처 받았다. 불가항력적 의료사고에도 형사 처벌하는 번위기가 가중되며, 필수의료 분야는 잠재적 범죄자의 위험까지 감수해야만 하는 아슬아슬한 줄타기 영역이 됐다. 존경이 사라진 의료현장에서 사명과 보람으로 자리를 지키던 필수의료진들은 돈과 위험부담을 놓고 고민에 빠진다. 가장 시급한 문제는 이것이다. 소위 현타와 상대적 박탈감에 빠진 다수의 필수의료진들이 현장을 떠나고 있다. 사람을 갈아 넣어 유지되던 대한민국 의료체계에서 필수의료 현장을 지키던 전문 인력의 누수로 인한 파급력과 붕괴 속도는 실로 어마어마하다. 필수의료 문제를 해결하기 위해 의대증원을 선택한다면, 정부가 기대하는 낙수 효과가 작동한다고 해도 의료 현장에 적용되는 시점은 10년 뒤다. 하지만 의대 증원 발표가 젊은 의사 사회에 몰고 올 또 다른 불안은 훨씬 더 심각한 누수 효과를 야기할 것이다. 당장의 필수과 기피 현상을 악화시키고 이미 현장에서 고군분투 중인 필수 전문 인력들의 사기를 떨어뜨리며 필수 전문인력 이탈 속도를 증가시킬 것이다. 결국 필수의료 현장의 붕괴를 가속화할 수밖에 없다. 의대 정원을 아무리 늘려봐야 젊은 의사들이 필수의료 분야를 빠져나가면 아무짝에 쓸모가 없다. 자유민주주의 국가 대한민국에서 진로선택의 자유를 침해하고 강제화하는 것도 불가능하다. 필수적인 분야로 수혈되지 않는 의사 수 증가는 오히려 의료비 증가를 야기하며 사회의 부담을 가중시킬 뿐이다. 출산율 0.78의 저출산, 생산인구 감소에 따른 저성장, 초고령사회에 진입한 늙어가는 대한민국에서 건강보험 재정 적자는 이미 예견된 일이다. 우리는 아직 수도꼭지를 잠그지 않았다. 필수의료 분야 의사 인력 수급 어려움을 단순히 수급 불균형 문제만으로 바라봐선 안 된다. 의사 인력 문제는 사람 중심 관점을 가져야 해결할 수 있다. 필수의료 분야에 종사하는 의료인에게 지금처럼 무작정 헌신과 소명을 강요하고 기대하는 것은 환자에게도 국민에게도 안전하지 않다. 젊은 의사들이 필수의료를 기피하고 미용성형 분야로 가려는 본질을 파악해야 해결 가능한 문제다. 갈수록 위험부담은 커지는데 자부심조차 느낄 수 없는 필수의료 현장보다는 차라리 금전적 보상이 큰 미용성형 분야를 선택할 수밖에 없는 것이다. 저출산, 고령화 시대를 맞은 대한민국에 진짜 필요한 의사를 늘리는 방향은 숫자에만 매몰된 쉬운 방법으로는 절대 불가능하다. 무엇보다 현재 떠나고 있는 전문 인력들을 어떻게 지킬지 먼저 고민해야 한다. 현장 의료인의 처우 개선이 가장 시급한 문제 1번이다. 젊은 의사들을 숫자가 아닌 사람으로 여길 때만이 대한민국 의사 인력문제를 해결할 실마리가 보일 것이다. 무너지기 직전의 댐을 그대로 둔 채, 누수를 고려하지 않은 낙수를 기대하며, 비싼 물을 쏟아붓는 무서운 일이 부디 벌어지지 않기를 바란다. ※칼럼은 칼럼니스트의 개인적인 의견이며 본지의 편집방향과 일치하지 않을 수 있습니다.
Korean doctors ranked pharmaceutical companies with their best practices in digital marketing…’Pfizer’ ranked the top
Doctors ranked pharmaceutical companies with their best practices in digital marketingPfizer ranked the top from the foreign companies and Hanmi and Daewoong from local companies. Medigate conducted a survey for 2011 physicials different awareness level of pharmaceutical companies for different specialties. [관련기사=의사들이 꼽은 디지털마케팅 잘하는 제약회사...외국계 화이자 GSK 국내 한미 대웅] For three consecutive years, Pfizer, a foreign pharmaceutical company, has been rated as the top company by doctors in their evaluation of digital marketing activities. Following Pfizer, GSK, AstraZeneca, and MSD received favorable assessments in that order. Among domestic pharmaceutical companies, Hanmi Pharmaceutical has maintained its top position for four consecutive years, with Daewoong Pharmaceutical, Chong Kun Dang, and Il-Dong Pharmaceutical also receiving excellent evaluations in sequence. On the 12th of the month, the medical portal Medigate released the results of a survey titled Physicians Online Usage and Digital Marketing Awareness, conducted over the course of one week, from August 16th to 23rd, among 2,011 physician members. Among the 2,011 participating physicians, 750 (37.3%) worked in general hospitals (100 beds or more), 341 (16.9%) worked in hospitals or specialized clinics (less than 30-100 beds), and 920 (45.8%) were from private practices. By medical specialties, the distribution among the surveyed physicians was as follows: Internal Medicine had the highest count with 508 individuals (25%), followed by Family Medicine with 303 (15%), General Practice with 182 (9%), Anesthesiology with 97 (5%), Pediatrics with 91 (5%), Obstetrics and Gynecology with 90 (4%), Orthopedic Surgery with 83 (4%), Psychiatry with 74 (4%), Physical Medicine and Rehabilitation with 73 (4%), Otorhinolaryngology with 72 (4%), Urology with 71 (4%), and Neurology with 71 (4%). Additionally, various other specialists in fields such as Surgery, Dermatology, Ophthalmology, Radiology, Plastic Surgery, Neurosurgery, and more participated in the survey. Over the past three years, there has been a consistent trend in the top three preferred sites for medical information updates. Among these, specialized websites for physicians were the most preferred, accounting for 71.5%. The usage rates of medical news outlets and individual pharmaceutical company websites have shown a slight increase compared to the previous year. In particular, in hospitals with over 300 beds, there is a relatively higher tendency to use domestic and international journal or association websites. On the other hand, in private clinics, sites operated by pharmaceutical companies and specialized websites for physicians were reported as the primary sources of information. Following last year, Pfizer and Hanmi Pharmaceutical continue to stand out as pharmaceutical companies with excellent digital marketing activities. Foreign pharmaceutical companies rated highly for their digital marketing activities, with Pfizer securing the top position for three consecutive years at 58.8%. Following Pfizer, companies like GSK, AstraZeneca, MSD, and Novartis also received favorable assessments. In this survey allowing multiple responses, the evaluation of excellent companies was based on various digital marketing strategies such as web symposiums (webinars), e-details (product and disease information conveyed through websites), virtual calls (video details by pharmaceutical representatives), emails, and KakaoTalk/text messages. GSK received a rating of 28.3%, AstraZeneca 22%, MSD 21.8%, and Novartis 18.2% in these specific categories. The results showed that Oganon received 63.9% as an excellent company in web symposiums, AstraZeneca obtained 43.6% in e-details, Novonordisk acquired 16.5% in virtual calls, Sanofi got 13.7% in emails, and Novonordisk also secured 7.2% in KakaoTalk/text messages. Furthermore, when analyzing the proportion of physicians who rated the digital marketing activities of these pharmaceutical companies as excellent based on whether they were in private clinics or hospitals with over 300 beds, the companies with a higher ratio of private clinic physicians were Novonordisk, GSK, and MSD. On the other hand, companies with a higher proportion of physicians from hospitals with over 300 beds were BMS, Abbott, and Roche. The rankings of foreign pharmaceutical companies in terms of digital marketing awareness varied according to their primary products across different medical specialties. While Pfizer, as the overall top company, showed the highest recognition in most medical departments such as Internal Medicine, Family Medicine, General Practice, Anesthesiology, and Orthopedic Surgery, the distribution and percentages were quite similar across these specialties. However, in Urology, GSK achieved the highest recognition at 62%, and in Ophthalmology, Novartis secured the top position with a recognition rate of 62%. In addition, in Obstetrics and Gynecology, Pfizer secured the top position with a recognition rate of 60%, while Bayer held the second position with a recognition rate of 44%. Similarly, in Psychiatry, Pfizer was the leader with 59% recognition, but Janssen followed closely in the second position with a recognition rate of 51%. Among domestic pharmaceutical companies, Hanmi Pharmaceutical has secured the top position for four consecutive years with 53.3% of physicians rating their digital marketing activities as excellent. Following Hanmi Pharmaceutical, Daewoong Pharmaceutical, Chong Kun Dang, Il-Dong Pharmaceutical, and Yuhan Corporation received excellent evaluations in that order. Specifically, Daewoong Pharmaceutical had a rating of 42.4%, followed by Chong Kun Dang at 16.5%, Il-Dong Pharmaceutical at 16.4%, and Yuhan Corporation at 15%. Among domestic pharmaceutical companies, in evaluating excellent companies based on different digital marketing strategies, Daewoong Pharmaceutical obtained 61.2% for web symposiums, GC Pharma received a rating of 43.1% for e-details, JW Pharmaceutical achieved 24.5% for virtual calls, Dong-A ST got 7.9% for emails, and Boryung garnered 11.1% for KakaoTalk/text messages. In the analysis of the proportion of physicians from private clinics and those from hospitals with over 300 beds who rated the digital marketing activities of these companies as excellent, the companies with a higher ratio of physicians from private clinics were Daewon Pharmaceutical, Chong Kun Dang, and GC Pharma. Conversely, companies with a higher proportion of physicians from hospitals with over 300 beds were Boryung, Jeil Pharmaceutical, and Dongkook Pharmaceutical, among others. The pharmaceutical company with the highest recognition on medical specialized websites is Hanmi Pharmaceutical, known as HMP, securing the first position. Following closely in second place is DoctorVille. According to this survey, the awareness of pharmaceutical companies on medical specialized websites saw a 1.6% increase from last year, with Hanmi Pharmaceuticals HMP maintaining an unchanging top position at 65.5%. The awareness survey was conducted based on the selection of sites that participants have visited at least once, allowing for multiple responses. The second position was held by Daewoong Pharmaceuticals DoctorVille with a recognition rate of 54.5%, which saw a decrease of 2% from last year. Third place was taken by Il-Dong Pharmaceuticals Hudaak with a recognition rate of 34.7%, marking a 2.1% increase from the previous year. Pfizers PfizerPro secured the fourth position with a notable advancement, rising by 14.6% from last year to achieve a recognition rate of 34.4%. This surge for Pfizer pushed MSDs MSDConnect to the fifth position with a recognition rate of 28.3%, causing it to drop from its previous fourth place. Particularly in this survey, differences in recognition rates based on the size of affiliated medical institutions were observed. Among physicians from hospitals with over 300 beds, the top-ranking companies with high recognition were Amgens Smart Amgen securing the first place, followed by Novartis MedHub in second place, and BMS BMS On at the third position. The membership rate on pharmaceutical medical specialized sites exhibited a similar yet distinct pattern compared to the recognition rates. The top position for membership, like the recognition rate, was held by Hanmi Pharmaceuticals HMP, securing 47.5%. Following closely in the second position was Daewoong Pharmaceuticals DoctorVille with a membership rate of 37.8%. The third position was secured by Il-Dong Pharmaceuticals Hudaak with a membership rate of 20.2%. The fourth place was Daewon Pharmaceuticals Detox with a membership rate of 12.9%, and the fifth place was Chong Kun Dangs MediView. Even after the pandemic, physicians continue to show a preference for digital marketing, and a combination of online and offline channel mix appears to be effective. According to a survey by Medigate involving 2,011 physicians, 85.5% of them responded positively to the impact of digital marketing on prescriptions. Furthermore, a significant proportion expressed a desire for a visit from sales representatives after obtaining information online. These results indicate the effectiveness of a blended approach utilizing both online and offline channels. Even after the transition to the COVID-19 post-pandemic phase, it has been evident that in pharmaceutical company marketing targeting physicians, digital marketing continues to play a significant role. This is attributed to the analysis indicating that online digital marketing has a positive impact on physicians specialized prescription practices. The medical portal Medigate presented the results of a survey titled Physicians Online Usage and Digital Marketing Awareness conducted from August 16th to 23rd among 2,011 physician members. Among the participating physicians, 37.3% (750 individuals) worked in general hospitals (100 beds or more), 16.9% (341 individuals) worked in hospitals or specialized clinics (less than 30-100 beds), and 45.8% (920 individuals) were from private practices. The continued usefulness of online platforms and a willingness to engage in future marketing, both online and offline in one-on-one interactions, have been observed. The top activity, as indicated by physicians when asked to choose the most beneficial among pharmaceutical companies sales and marketing activities, was offline symposiums and seminars (40%). Following that, web symposiums ranked second (32.4%). Sales representatives visits for product details ranked third (20.1%), while e-details via websites for product and disease information ranked fourth (7%). Video details with pharmaceutical representatives ranked fifth (0.5%). However, when physicians were asked about their willingness to participate in future sales and marketing activities by pharmaceutical companies, allowing for multiple responses, offline symposiums and seminars were still the top choice with 70% of respondents selecting it. Notably, web symposiums (webinars) were a close second, with 67.3% of respondents choosing this option, showing that there wasnt a significant difference between online and offline preferences. The third spot was claimed by product detailing through sales representatives visits (40.4%), followed by e-details via websites for product and disease information (32.5%) in the fourth position. Video details with pharmaceutical representatives held the fifth position with 8%. Overall, physicians exhibit a preference ratio of 60:40 in favor of offline activities, although there has been a slight decrease in this preference from the previous years ratio of 63:37. Particularly in future pharmaceutical company marketing activities where participation is intended, the offline and online ratio stands at 51:49, closely approaching a 1:1 balance. The perception of valuable marketing activities by pharmaceutical companies among physicians has shown an increasing positive inclination towards the usefulness of online strategies when compared between 2017 and 2023. In 2017, the evaluation of the usefulness of face-to-face marketing activities such as offline symposiums and sales representatives providing product details stood at a high of 84%. However, by 2023, this assessment dropped by 23.9 percentage points to 60.1%. Conversely, in 2017, the assessment of the usefulness of online activities such as web symposiums and online product detailing stood at a low of 14%. By 2023, this evaluation increased significantly by 25.4%, reaching 39.4%. Even after the COVID-19 pandemic, there continues to be a positive assessment of the impact of digital marketing on prescriptions. The preference for digital marketing translated into increased prescriptions. The question regarding the impact of digital marketing on prescription witnessed a substantial rise from 83.5% in 2022 to 86.6% in 2022. Despite a slight decrease to 85.5% in 2023 after the end of the COVID-19 pandemic, a consistent positive evaluation remained evident. The percentage of respondents who answered yes to the question about whether online promotional activities by pharmaceutical companies influenced prescription increases was notably high across various hospital sizes: 81.6% for hospitals with 300 or more beds, 86.3% for hospitals with 100-300 beds, and 82.4% for hospitals with 10-300 beds, including specialty hospitals. In particular, for clinics with 30 beds or fewer, in 2023, 88.5% of physicians responded yes, marking a 2.2% increase from the previous year and a cumulative rise of 7% over three years, indicating a consistent upward trend. When examining the impact of digital marketing on prescriptions by medical specialty, 85.5% of all respondents reported that online promotional activities had a positive impact on prescription increases. In particular, physicians specializing in family medicine, plastic surgery, pediatrics, urology, surgery, internal medicine, obstetrics and gynecology, dermatology, and ophthalmology were analyzed to have a higher-than-average impact from online promotions. The question regarding the primary factor influencing prescription changes due to digital marketing activities indicated that web symposiums ranked first (70.2%), followed by E-details (22.6%). Combining the top two factors, the total was 90.9% for web symposiums and 75.5% for E-details. This suggests that a combination of web symposiums and E-details is effective in online marketing activities. When asked about the most effective way for pharmaceutical companies to deliver product and disease information, doctors indicated a preference for a method where they first acquire information online through webinars, emails, websites, etc., and then have sales representatives visit for additional detailing. This approach was favored by 39% of doctors. The second most preferred method involved sales representative visits for detailing, followed by additional information received online, accounting for 29.2%. Additionally, 12.6% of respondents indicated that online product information via webinars, emails, or websites was sufficient without the need for further details through visits. The method of receiving all information regularly through sales representatives showed the lowest preference at 8.8%. Regarding the increasingly popular Kakao Chnnel, the number of participating doctors wo registered on Kakao Channel reached 848 out of the total participants, accounting for 42%. This indicated a 10% increase from the previous year. Dermatology, Plastic Surgery, Family Medicine, Internal Medicine, and General Practice showed response rates higher than the average among medical specialties. by Woon Jo
Emphasizing collaboration with multiple ministries including education and labor [National assembly symposium]④
Media and Ministry of Health in Consensus for sleep health policy change... Emphasizing collaboration with multiple ministries including education and labor Enhancing sleep health awareness: National assembly symposium④ Inclusion in Ministry of Welfares Health Plan 2030, Potential integration into ministry of educations student health checkups, and Employment Ministrys Sleep Health Reporting Program MedigateNews co-hosts national parliamentary ymposium to improve public awareness on sleep health. South Korea, known for severe sleep deprivation, records the lowest average sleep duration of 7 hours and 41 minutes, falling far behind the OECD average of 8 hours and 22 minutes. Korean sleep satisfaction scores a mere 2.87 out of 5, displaying a consistent decline annually. This persistent sleep deficit and deteriorating sleep quality have led to a nationwide economic loss estimated at 11.497 trillion won. The National Parliamentary Symposium for Enhancing Public Awareness on Sleep Health held on August 30th at the National Assemblys Member Conference Room marked the first-ever parliamentary symposium addressing the topic of sleep health. Organized by the Democratic Partys Representative Shin Hyun-young, the symposium was jointly organized by all sleep-related academic societies: the Korean Academy of Sleep Medicine, Korean Society of Sleep Medicine, Korean Sleep Research Society, Korean Society of Sleep and Breathing, Korean Academy of Dental Sleep Medicine, Korean Society of Sleep Research, Korean Sleep Technology Association, and MediGate News. This event and article received support from the Government Advertising Fund for media promotion. The government and the media expressed their willingness to continuously collaborate with multiple sleep-related societies claims, aiming to lead proactive changes. The Dong-A Ilbo journalist, Lee Jin-Han, who is also a medical doctor, stated, The fact that various sleep-related societies have come together is a significant step forward. In the future, continuing to unite and establish organizations like the Korea National Sleep Foundation (KNSF) seems to be a good option. He added, While there are individual claims from different societies, it is crucial to focus on conveying the importance of sleep health to the public with a unified voice. The journalist also pointed out, One regrettable aspect is the absence of a nationwide campaign related to sleep. Recently, smartphones, YouTube, social media, and games, all have connections with sleep health. There have been campaigns encouraging people to put their phones aside while sleeping, addressing this issue. He emphasized, It would be great to have a similar campaign where the public can participate. Its disappointing that representatives from the Ministry of Education and other authorities responsible for student policies were not present at this event. New counseling fees for education on positive airway pressure therapy for sleep apnea and revisions needed for narcolepsy diagnosis The head of the Health Policy Division at the Ministry of Health and Welfare, Kwak Sun-Heon, expressed, Its incredibly challenging to bring all the relevant societies together, making this seminar highly meaningful. When I was first invited to attend, I thought sleep health should be handled by the department responsible for mental health. However, after participating and hearing the discussions, it seems that managing it solely under the Department of Psychiatry is not straightforward. In reality, there has been a lack of awareness regarding sleep health at the level of health policy. Kwak emphasized, The most urgent priority among the proposed initiatives is improving public awareness of sleep health. I believe research can be conducted to distribute promotional materials during health education sessions at public health centers and schools. Furthermore, he stated, The Korea Health Promotion Institute is exploring new themes related to health, and it is essential to engage in discussions on sleep health issues at the institute level. Coordinating student health check-ups with the Ministry of Education and creating sleep health reporting programs with the Ministry of Employment and Labor could be feasible. Kwak highlighted, When considering the areas the Ministry of Health and Welfare can address, we plan the National Health Promotion Comprehensive Plan (Health Plan 2030) every ten years. We can align this with future initiatives like sleep examinations for adolescents, enabling preparatory work. Additionally, the Ministry of Employment and Labor can incorporate elements related to long working hours, overwork-related risks, and sleep disorders among workers, allowing for proactive screening. By Kyung-dae Ha